Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
Clinical trial NCT04127227 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04127227
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-09
- Primary completion
- 2023-07-20
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.